| Motif ID |
Motif Logo |
Scanned Score Distribution |
Frequency of Motif |
Replicability Score |
Evolutionary Conservation Score |
Gene Targets |
Gene Ontology of CpGMM targets |
| CG_h9laurent_promoter_p_PM_12_31_2 |
 |
 |
2 |
0.5 |
5.27E-05 |
CHST3 |
chondroitin 6-sulfotransferase activity [MF] |
| CG_h9laurent_promoter_p_PM_18_4_7 |
 |
 |
1 |
0.25 |
3.61E-05 |
ACAT1,
LEP |
adipose tissue development [BP] |
| CG_h9laurent_promoter_p_PM_16_2_1 |
 |
 |
1 |
0.25 |
8.68E-05 |
BCAM |
laminin receptor activity [MF] |
| CG_h9laurent_promoter_p_PM_12_36_2 |
 |
 |
2 |
0.5 |
8.29E-05 |
TP73,
FOXN1 |
defense response [BP],
cerebrospinal fluid secretion [BP] |
| CG_h9laurent_promoter_p_PM_12_12_3 |
 |
 |
1 |
0.25 |
5.28E-05 |
AMPD3 |
AMP catabolic process [BP] |
| CG_h9laurent_promoter_p_PM_20_20_4 |
 |
 |
1 |
0.25 |
6.59E-05 |
CYP21A2 |
steroid 21-monooxygenase activity [MF] |
| CG_h9laurent_promoter_p_PM_14_6_5 |
 |
 |
5 |
0.5 |
1.48E-05 |
PEX14 |
protein import into peroxisome matrix, translocation [BP],
negative regulation of protein homotetramerization [BP],
peroxisome transport along microtubule [BP],
protein import into peroxisome matrix, substrate release [BP] |
| CG_h9laurent_promoter_p_PM_12_13_1 |
 |
 |
2 |
0.5 |
2.19E-05 |
CTPS1,
GCDH |
glutaryl-CoA dehydrogenase activity [MF],
CTP synthase activity [MF],
'de novo' CTP biosynthetic process [BP] |
| CG_h9laurent_promoter_p_PM_18_10_9 |
 |
 |
1 |
0.25 |
3.42E-05 |
KPNA2,
BCKDHA,
LRP1 |
3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity [MF],
negative regulation of platelet-derived growth factor receptor-beta signaling pathway [BP],
protein transporter activity [MF],
M phase specific microtubule process [BP],
lipoprotein transporter activity [MF],
alpha-ketoacid dehydrogenase activity [MF] |
| CG_h9laurent_promoter_p_PM_20_8_3 |
 |
 |
1 |
0.25 |
3.97E-05 |
MALT1,
FTSJD2 |
B-1 B cell differentiation [BP],
mRNA methylation [BP],
mRNA (nucleoside-2'-O-)-methyltransferase activity [MF] |
| CG_h9laurent_promoter_p_PM_20_1_3 |
 |
 |
1 |
0.25 |
6.41E-05 |
DNM1L |
dynamin polymerization involved in mitochondrial fission [BP],
membrane fission involved in mitochondrial fission [BP] |
| CG_h9laurent_promoter_p_PM_12_17_2 |
 |
 |
1 |
0.25 |
1.02E-04 |
HGSNAT |
heparan-alpha-glucosaminide N-acetyltransferase activity [MF] |
| CG_h9laurent_promoter_p_PM_18_3_4 |
 |
 |
1 |
0.25 |
3.05E-05 |
MAML1 |
atrioventricular node cell development [BP] |
| CG_h9laurent_promoter_p_PM_18_8_4 |
 |
 |
1 |
0.25 |
4.01E-05 |
SLC50A1,
OTC |
glucoside transport [BP],
ornithine carbamoyltransferase activity [MF],
ornithine carbamoyltransferase complex [CC],
response to biotin [BP],
glucoside transmembrane transporter activity [MF] |
| CG_h9laurent_promoter_p_PM_14_5_7 |
 |
 |
5 |
0.5 |
1.01E-04 |
POLR2F,
SUPT5H |
7-methylguanosine mRNA capping [BP] |
| CG_h9laurent_promoter_p_PM_20_6_8 |
 |
 |
1 |
0.25 |
1.48E-04 |
AIP,
ARHGEF10 |
positive regulation of GTP catabolic process [BP],
negative regulation of cyclic-nucleotide phosphodiesterase activity [BP],
GAF domain binding [MF] |
| CG_h9laurent_promoter_p_PM_20_5_5 |
 |
 |
1 |
0.25 |
5.34E-05 |
AZU1 |
positive regulation of fractalkine biosynthetic process [BP],
positive regulation of interleukin-1 beta biosynthetic process [BP] |
| CG_h9laurent_promoter_p_PM_18_5_6 |
 |
 |
1 |
0.25 |
8.41E-05 |
SLC2A4 |
amylopectin biosynthetic process [BP] |
| CG_h9laurent_promoter_p_PM_20_2_10 |
 |
 |
1 |
0.25 |
3.80E-05 |
PTPMT1,
SAT1 |
phosphatidylglycerophosphatase activity [MF],
spermidine binding [MF] |
| CG_h9laurent_promoter_p_PM_12_33_2 |
 |
 |
1 |
0.25 |
5.81E-04 |
PCDHGA11,
PCDHGA12,
MYBPC2,
PCDHGB4,
PCDHGA6,
FXYD5 |
homophilic cell adhesion [BP],
calcium-dependent cell-cell adhesion [BP],
calcium ion binding [MF],
negative regulation of calcium-dependent cell-cell adhesion [BP],
cell adhesion [BP] |
| CG_h9laurent_promoter_p_PM_12_2_2 |
 |
 |
1 |
0.25 |
4.29E-04 |
SCG5,
CRCP |
DNA polymerase III complex [CC],
neuropeptide signaling pathway [BP] |
| CG_h9laurent_promoter_p_PM_14_4_5 |
 |
 |
1 |
0.25 |
4.62E-05 |
CETP,
IDO2 |
triglyceride binding [MF],
indoleamine 2,3-dioxygenase activity [MF] |
| CG_h9laurent_promoter_p_PM_12_6_3 |
 |
 |
4 |
0.75 |
4.15E-05 |
BICD1,
ADIPOQ,
CNIH3 |
regulation of membrane potential [BP],
negative regulation of platelet-derived growth factor receptor-alpha signaling pathway [BP],
response to linoleic acid [BP],
detection of oxidative stress [BP],
negative regulation of phospholipase C activity [BP],
host cell viral assembly compartment [CC],
negative regulation of metanephric mesenchymal cell migration [BP],
proteinase activated receptor binding [MF],
negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway [BP],
negative regulation of eukaryotic cell surface binding [BP],
regulation of proteinase activated receptor activity [BP],
positive regulation of metanephric glomerular visceral epithelial cell development [BP],
positive regulation of renal albumin absorption [BP] |
| CG_h9laurent_promoter_p_PM_16_18_3 |
 |
 |
2 |
0.5 |
5.38E-05 |
ITGAV,
GPX4 |
negative regulation of entry of bacterium into host cell [BP],
alphav-beta3 integrin-IGF-1-IGF1R complex [CC],
entry of symbiont into host cell by promotion of host phagocytosis [BP],
phospholipid-hydroperoxide glutathione peroxidase activity [MF] |
| CG_h9laurent_promoter_p_PM_16_1_15 |
 |
 |
2 |
0.5 |
1.53E-04 |
SMS,
MDH2,
MAFF,
GALT |
regulation of epidermal cell differentiation [BP],
malate dehydrogenase (NADP+) activity [MF],
spermine synthase activity [MF],
UDP-glucose:hexose-1-phosphate uridylyltransferase activity [MF] |
| CG_h9laurent_promoter_p_PM_12_22_2 |
 |
 |
1 |
0.25 |
1.44E-04 |
CACNA1D,
ADSL |
N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity [MF],
membrane repolarization involved in regulation of SA node cell action potential [BP],
voltage-gated calcium channel activity involved in regulation of cardiac muscle cell action potential [MF],
voltage-gated calcium channel activity involved in regulation of SA node cell action potential [MF],
(S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido)succinate AMP-lyase (fumarate-forming) activity [MF] |
| CG_h9laurent_promoter_p_PM_12_25_2 |
 |
 |
2 |
0.5 |
9.55E-05 |
TP73,
HOOK3 |
protein localization to centrosome [BP],
cerebrospinal fluid secretion [BP] |
| CG_h9laurent_promoter_p_PM_14_21_3 |
 |
 |
1 |
0.25 |
2.76E-05 |
FOXA3 |
positive regulation of hepatocyte differentiation [BP] |
| CG_h9laurent_promoter_p_PM_18_16_3 |
 |
 |
1 |
0.25 |
4.77E-05 |
ZMIZ1,
SLC6A17,
MARCH9,
VRK1 |
Golgi stack [CC],
vitellogenesis [BP],
glycine transport [BP],
Golgi disassembly [BP] |
| CG_h9laurent_promoter_p_PM_16_19_5 |
 |
 |
1 |
0.25 |
4.42E-05 |
SCN1B |
voltage-gated sodium channel activity involved in regulation of Purkinje myocyte action potential [MF],
membrane depolarization involved in regulation of Purkinje myocyte cell action potential [BP] |
| CG_h9laurent_promoter_p_PM_16_12_3 |
 |
 |
2 |
0.25 |
7.52E-05 |
L3MBTL1 |
SAM domain binding [MF] |
| CG_h9laurent_promoter_p_PM_12_24_3 |
 |
 |
3 |
0.5 |
6.77E-06 |
TAF1,
IL23R |
interleukin-23 receptor complex [CC],
interleukin-23-mediated signaling pathway [BP],
regulation of transcription involved in G2/M-phase of mitotic cell cycle [BP],
interleukin-23 binding [MF],
interleukin-23 receptor activity [MF] |
| CG_h9laurent_promoter_p_PM_12_5_2 |
 |
 |
2 |
0.5 |
1.99E-05 |
FOXL1 |
visceral mesoderm-endoderm interaction involved in midgut development [BP] |
| CG_h9laurent_promoter_p_PM_14_23_4 |
 |
 |
3 |
0.5 |
1.36E-04 |
MYLK2,
CCNB1 |
positive regulation of attachment of spindle microtubules to kinetochore [BP],
cellular response to iron(III) ion [BP],
regulation of chromosome condensation [BP],
response to DDT [BP],
kinase activity [MF],
cardiac muscle cell differentiation [BP] |
| CG_h9laurent_promoter_p_PM_12_14_2 |
 |
 |
2 |
0.5 |
1.15E-04 |
PIGL,
CSF3,
SHBG,
FXN,
NDEL1,
PIGB |
granulocyte colony-stimulating factor receptor binding [MF],
primary spermatocyte growth [BP],
regulation of ferrochelatase activity [BP],
iron chaperone activity [MF],
preassembly of GPI anchor in ER membrane [BP],
N-acetylglucosaminylphosphatidylinositol deacetylase activity [MF],
C-terminal protein lipidation [BP],
oligopeptidase activity [MF],
GPI anchor biosynthetic process [BP],
positive regulation of axon extension [BP] |
| CG_h9laurent_promoter_p_PM_20_9_5 |
 |
 |
1 |
0.25 |
6.63E-05 |
EIF4H,
TNRC6C |
nucleotide binding [MF] |
| CG_h9laurent_promoter_p_PM_12_20_4 |
 |
 |
3 |
0.75 |
1.75E-05 |
FAHD1,
CCDC88B,
DLL4,
APC2 |
acylpyruvate hydrolase activity [MF],
acetylpyruvate hydrolase activity [MF],
fumarylpyruvate hydrolase activity [MF],
blood vessel lumenization [BP],
microtubule binding [MF] |
| CG_h9laurent_promoter_p_PM_16_4_7 |
 |
 |
2 |
0.5 |
3.93E-05 |
XPOT,
PIGL |
N-acetylglucosaminylphosphatidylinositol deacetylase activity [MF],
tRNA export from nucleus [BP] |
| CG_h9laurent_promoter_p_PM_16_23_3 |
 |
 |
1 |
0.25 |
5.82E-05 |
HSPA4 |
protein import into mitochondrial outer membrane [BP] |
| CG_h9laurent_promoter_p_PM_20_17_6 |
 |
 |
1 |
0.25 |
6.69E-04 |
PCDHGB5,
PCDHGA12,
PCDHGA11,
PCDHGA6 |
homophilic cell adhesion [BP],
calcium ion binding [MF] |
| CG_h9laurent_promoter_p_PM_12_7_2 |
 |
 |
3 |
0.5 |
1.40E-04 |
EGLN2,
UBE2B,
QTRT1,
TXNDC2 |
negative regulation of histone phosphorylation [BP],
nutrient reservoir activity [MF],
cell redox homeostasis [BP],
queuosine biosynthetic process [BP],
positive regulation of reciprocal meiotic recombination [BP] |
| CG_h9laurent_promoter_p_PM_16_10_2 |
 |
 |
1 |
0.25 |
4.20E-05 |
FEM1A |
regulation of ubiquitin-protein ligase activity [BP],
EP4 subtype prostaglandin E2 receptor binding [MF] |
| CG_h9laurent_promoter_p_PM_16_3_4 |
 |
 |
1 |
0.25 |
1.22E-05 |
USP14 |
tRNA guanylyltransferase activity [MF] |
| CG_h9laurent_promoter_p_PM_12_23_2 |
 |
 |
1 |
0.25 |
5.36E-05 |
ASPA,
OGG1,
CORO1A |
8-oxo-7,8-dihydroguanine DNA N-glycosylase activity [MF],
oxidized purine nucleobase lesion DNA N-glycosylase activity [MF],
negative regulation of actin nucleation [BP],
uropod organization [BP],
aspartoacylase activity [MF] |
| CG_h9laurent_promoter_p_PM_12_8_5 |
 |
 |
2 |
0.5 |
1.77E-04 |
PCDHGA11,
PKP3,
PCDHGB5,
PCDHGB4,
PCDHGA6,
CD97 |
homophilic cell adhesion [BP],
calcium ion binding [MF],
cell adhesion [BP] |
| CG_h9laurent_promoter_p_PM_14_12_2 |
 |
 |
2 |
0.5 |
5.82E-05 |
NT5M,
MTHFD1L |
dUMP catabolic process [BP],
formate-tetrahydrofolate ligase activity [MF] |
| CG_h9laurent_promoter_p_PM_12_26_4 |
 |
 |
2 |
0.5 |
7.11E-05 |
CERS4 |
phospholipid metabolic process [BP] |
| CG_h9laurent_promoter_p_PM_14_25_6 |
 |
 |
1 |
0.25 |
3.48E-05 |
KAT2B |
regulation of protein ADP-ribosylation [BP],
lysine N-acetyltransferase activity [MF] |
| CG_h9laurent_promoter_p_PM_12_21_1 |
 |
 |
2 |
0.5 |
4.94E-05 |
PRPH |
C-fiber [CC] |
| CG_h9laurent_promoter_p_PM_14_8_2 |
 |
 |
2 |
0.5 |
5.67E-04 |
PCDHGB7,
PCDHGB5,
PCDHGA12,
PCDHGB4,
PCDHGA11 |
homophilic cell adhesion [BP],
calcium ion binding [MF],
cell adhesion [BP] |
| CG_h9laurent_promoter_p_PM_12_35_5 |
 |
 |
2 |
0.5 |
1.02E-04 |
DLAT,
PRDX5 |
regulation of apoptosis involved in tissue homeostasis [BP],
peroxynitrite reductase activity [MF],
dihydrolipoyllysine-residue acetyltransferase activity [MF] |
| CG_h9laurent_promoter_p_PM_18_1_22 |
 |
 |
1 |
0.25 |
2.21E-05 |
MTHFD2,
MSH6,
PRKAA2,
ENO3 |
[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity [MF],
[acetyl-CoA carboxylase] kinase activity [MF],
oxidized purine DNA binding [MF],
methylenetetrahydrofolate dehydrogenase (NAD+) activity [MF],
magnesium ion binding [MF],
single thymine insertion binding [MF],
glycolysis [BP] |
| CG_h9laurent_promoter_p_PM_16_16_7 |
 |
 |
1 |
0.25 |
1.37E-05 |
NAGLU,
GLYCTK,
SRGN |
maintenance of granzyme B location in T cell secretory granule [BP],
T cell secretory granule organization [BP],
alpha-N-acetylglucosaminidase activity [MF],
maintenance of protease location in mast cell secretory granule [BP],
glycerate kinase activity [MF] |
| CG_h9laurent_promoter_p_PM_16_13_7 |
 |
 |
2 |
0.25 |
6.00E-05 |
RAB7A,
FDFT1,
SLC9A3R1,
ACER3 |
farnesyl-diphosphate farnesyltransferase activity [MF],
phytosphingosine biosynthetic process [BP],
squalene synthase activity [MF],
renal phosphate ion absorption [BP],
bile acid secretion [BP],
epidermal growth factor catabolic process [BP],
phytoceramidase activity [MF] |
| CG_h9laurent_promoter_p_PM_16_11_2 |
 |
 |
2 |
0.5 |
3.86E-05 |
GCDH,
MCHR1 |
glutaryl-CoA dehydrogenase activity [MF],
melanin-concentrating hormone receptor activity [MF] |
| CG_h9laurent_promoter_p_PM_14_28_5 |
 |
 |
1 |
0.25 |
1.49E-05 |
ATG13 |
ULK1-ATG13-FIP200 complex [CC] |
| CG_h9laurent_promoter_p_PM_18_13_4 |
 |
 |
1 |
0.25 |
2.25E-04 |
QTRT1,
TRMT61A |
queuine tRNA-ribosyltransferase activity [MF],
queuosine biosynthetic process [BP],
tRNA (adenine-N1-)-methyltransferase activity [MF],
tRNA (m1A) methyltransferase complex [CC] |
| CG_h9laurent_promoter_p_PM_12_4_2 |
 |
 |
2 |
0.5 |
7.85E-05 |
EPHX1 |
cis-stilbene-oxide hydrolase activity [MF] |
| CG_h9laurent_promoter_p_PM_14_22_4 |
 |
 |
2 |
0.5 |
1.75E-05 |
SLC25A37 |
iron ion transmembrane transporter activity [MF],
mitochondrial iron ion transport [BP] |
| CG_h9laurent_promoter_p_PM_12_27_2 |
 |
 |
1 |
0.25 |
2.39E-05 |
CARM1,
SUPV3L1,
CLEC3B |
mitochondrial RNA surveillance [BP],
mitochondrial ncRNA surveillance [BP],
histone H3-R17 methylation [BP],
histone methyltransferase activity (H3-R17 specific) [MF],
3'-5' RNA helicase activity [MF],
mitochondrial mRNA surveillance [BP],
kringle domain binding [MF] |
| CG_h9laurent_promoter_p_PM_16_20_4 |
 |
 |
1 |
0.25 |
8.89E-05 |
MPG,
MPV17L,
SLC12A5 |
DNA-7-methylguanine glycosylase activity [MF],
DNA-7-methyladenine glycosylase activity [MF],
DNA-3-methylguanine glycosylase activity [MF],
DNA-3-methyladenine glycosylase activity [MF],
negative regulation of hydrogen peroxide biosynthetic process [BP],
thermosensory behavior [BP] |
| CG_h9laurent_promoter_p_PM_20_12_10 |
 |
 |
1 |
0.25 |
1.10E-04 |
SGOL2,
WNT8B |
negative regulation of anterior neural cell fate commitment of the neural plate by Wnt receptor signaling pathway [BP],
meiotic sister chromatid cohesion, centromeric [BP] |
| CG_h9laurent_promoter_p_PM_14_18_4 |
 |
 |
2 |
0.5 |
2.73E-05 |
NDEL1,
RAD51 |
oligopeptidase activity [MF],
positive regulation of DNA ligation [BP] |
| CG_h9laurent_promoter_p_PM_18_15_3 |
 |
 |
1 |
0.25 |
1.40E-05 |
AK4,
UBE2D2,
CAPN2,
FMN2,
EPO |
tetracycline metabolic process [BP],
meiotic chromosome movement towards spindle pole [BP],
regulation of transcription from RNA polymerase II promoter in response to hypoxia [BP],
carbon tetrachloride metabolic process [BP],
response to hypoxia [BP],
cellular response to hypoxia [BP] |
| CG_h9laurent_promoter_p_PM_14_20_3 |
 |
 |
2 |
0.5 |
1.20E-05 |
MIF,
GLI2 |
spinal cord ventral commissure morphogenesis [BP],
smoothened signaling pathway involved in ventral spinal cord interneuron specification [BP],
notochord regression [BP],
smoothened signaling pathway involved in spinal cord motor neuron cell fate specification [BP],
positive regulation of prostaglandin secretion involved in immune response [BP],
phenylpyruvate tautomerase activity [MF] |
| CG_h9laurent_promoter_p_PM_14_3_3 |
 |
 |
1 |
0.25 |
1.85E-05 |
GATC |
regulation of translational fidelity [BP],
glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity [MF],
glutaminyl-tRNAGln biosynthesis via transamidation [BP],
glutamyl-tRNA(Gln) amidotransferase complex [CC] |
| CG_h9laurent_promoter_p_PM_16_24_2 |
 |
 |
2 |
0.5 |
3.63E-04 |
PCDHGB5,
PCDHGA12,
PCDHGA11,
PCDHGB7 |
homophilic cell adhesion [BP],
calcium ion binding [MF] |
| CG_h9laurent_promoter_p_PM_20_19_4 |
 |
 |
1 |
0.25 |
5.13E-05 |
SNRPC |
U1 snRNP [CC] |
| CG_h9laurent_promoter_p_PM_20_3_6 |
 |
 |
1 |
0.25 |
2.16E-05 |
CAPN3,
AMDHD2 |
autolysis [BP],
N-acetylglucosamine-6-phosphate deacetylase activity [MF],
G1 to G0 transition involved in cell differentiation [BP] |
| CG_h9laurent_promoter_p_PM_12_18_2 |
 |
 |
1 |
0.25 |
1.25E-04 |
CAV3 |
negative regulation of sarcomere organization [BP],
regulation of nerve growth factor receptor activity [BP],
regulation of signal transduction by receptor internalization [BP] |
| CG_h9laurent_promoter_p_PM_12_32_3 |
 |
 |
2 |
0.5 |
2.34E-05 |
ID2,
ZAP70,
ABAT,
AMDHD2 |
4-aminobutyrate transaminase activity [MF],
(S)-3-amino-2-methylpropionate transaminase activity [MF],
positive regulation of transcription involved in G1/S phase of mitotic cell cycle [BP],
beta selection [BP],
succinate-semialdehyde dehydrogenase binding [MF],
N-acetylglucosamine-6-phosphate deacetylase activity [MF],
4-aminobutyrate transaminase complex [CC],
gamma-aminobutyric acid catabolic process [BP],
T cell aggregation [BP] |
| CG_h9laurent_promoter_p_PM_12_30_3 |
 |
 |
2 |
0.5 |
2.58E-05 |
TGS1 |
RNA trimethylguanosine synthase activity [MF],
7-methylguanosine cap hypermethylation [BP] |
| CG_h9laurent_promoter_p_PM_16_5_3 |
 |
 |
1 |
0.25 |
3.41E-05 |
FEM1B |
regulation of DNA damage checkpoint [BP] |
| CG_h9laurent_promoter_p_PM_14_2_3 |
 |
 |
1 |
0.25 |
3.04E-05 |
COPG1,
PEX14 |
peroxisome transport along microtubule [BP],
organelle transport along microtubule [BP],
protein import into peroxisome matrix, substrate release [BP] |
| CG_h9laurent_promoter_p_PM_16_8_5 |
 |
 |
2 |
0.5 |
3.01E-05 |
PPP1R8 |
ribonuclease E activity [MF] |
| CG_h9laurent_promoter_p_PM_12_15_4 |
 |
 |
3 |
0.75 |
2.23E-05 |
THNSL2 |
2-oxobutyrate biosynthetic process [BP] |
| CG_h9laurent_promoter_p_PM_16_22_3 |
 |
 |
1 |
0.25 |
2.51E-05 |
SNAI1,
MPP6,
IGF1R |
inactivation of MAPKK activity [BP],
protein complex assembly [BP],
negative regulation of cell differentiation involved in embryonic placenta development [BP] |
| CG_h9laurent_promoter_p_PM_12_29_2 |
 |
 |
2 |
0.5 |
9.12E-05 |
AGK |
acylglycerol kinase activity [MF] |
| CG_h9laurent_promoter_p_PM_14_16_3 |
 |
 |
2 |
0.5 |
6.10E-05 |
NSMCE2,
XRCC6,
FBXO18 |
ATP-dependent DNA helicase activity [MF],
chromosome, telomeric region [CC] |
| CG_h9laurent_promoter_p_PM_14_24_3 |
 |
 |
3 |
0.5 |
2.99E-05 |
ALPL,
MACF1 |
posttranslational protein targeting to membrane [BP],
cementum mineralization [BP] |
| CG_h9laurent_promoter_p_PM_18_7_9 |
 |
 |
1 |
0.25 |
2.72E-05 |
SMARCB1,
RBL2,
ILF3,
POLR1B |
nucleolus [CC],
nucleologenesis [BP] |
| CG_h9laurent_promoter_p_PM_16_6_4 |
 |
 |
1 |
0.25 |
1.62E-04 |
SNRPB2,
NFX1 |
negative regulation of MHC class II biosynthetic process [BP],
U2 snRNP [CC] |
| CG_h9laurent_promoter_p_PM_12_28_2 |
 |
 |
2 |
0.5 |
8.30E-05 |
CAMK1D,
BCR,
ARHGAP26,
GCDH |
glutaryl-CoA dehydrogenase activity [MF],
positive regulation of phagocytosis [BP],
Rho GTPase activator activity [MF] |
| CG_h9laurent_promoter_p_PM_14_17_5 |
 |
 |
3 |
0.75 |
5.93E-05 |
PLAU,
CAMSAP3 |
regulation of receptor activity [BP],
microtubule minus-end binding [MF] |